Navigation Links
Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL

States have been infected with HCV, of whom 2.7 million are chronically infected.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

     Contact:

     Alan Roemer

     Vice President, Investor Relations & Corporate Communications

     

     Office: (609) 613-4125

alan.roemer@pharmasset.com

STATEMENTS IN THIS COMPANY PRESS RELEASE MAY CONSTITUTE FORWARD-LOOKING STATEMENTS AND ARE SUBJECT TO NUMEROUS RISKS AND UNCERTAINTIES, INCLUDING THE FAILURE OF CLEVUDINE AND R7128 TO PERFORM AS EXPECTED, THE COMPANY'S ABILITY TO ATTRACT AND RETAIN QUALIFIED PERSONNEL TO CONDUCT THE REQUIRED CLINICAL TRIALS OF CLEVUDINE AND R7128 , THE STATUS OF THE COMPANY'S HCV COLLABORATION WITH ROCHE, THE COMPANY'S FUTURE CAPITAL NEEDS TO FUND THE CLEVUDINE AND R7128 DEVELOPMENT PROGRAMS, THE COMPANY'S ABILITY TO OBTAIN ADDITIONAL FINANCING, THE COMPANY'S ABILITY TO OBTAIN REQUIRED REGULATORY APPROVALS FOR CLEVUDINE AND R7128, THE DEVELOPMENT OF COMPETITIVE HBV AND HCV PRODUCTS BY OTHERS, THE EXISTENCE OF THIRD-PARTY PATENT RIGHTS, AND OTHER RISKS INHERENT IN DISCOVERY AND DEVELOPMENT STAGE PROGRAMS AT A BIOTECHNOLOGY COMPANY. THE ACTUAL RESULTS FOR CLEVUDINE AND R7128 MAY DIFFER MATERIALLY FROM THOSE ANTICIPATED IN THIS COMPANY PRESS RELEASE. THE COMPANY DISCLAIMS ANY OBLIGATION TO UPDATE THE STATEMENTS CONTAINED IN THIS COMPANY PRESS RELEASE.

CONTACT: Alan Roemer, Vice President, Investor Relations & CorporateCommunications of Pharmasset, Inc., +1-609-613-4125, alan.roemer@pharmasset.com

Web site:




Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/29/2015)... Touro College has announced that it is supporting ... media marijuana licenses to be issued by the ... If CanniCare is selected, Touro would provide the ... college is supportive of medicinal development and research," said ... "There is still a great deal of research to be ...
(Date:7/29/2015)...  Henry Schein, Inc. (NASDAQ: HSIC ), ... and services to office-based dental, animal health and ... results. Net sales for the quarter ... increase of 0.5% compared with the second quarter ... local currencies and a 7.0% decline related to ...
(Date:7/29/2015)... CITY, Calif. , July 29, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... close on Monday, Aug 3rd, 2015. AcelRx management ... p.m. Eastern Time (1:30 p.m. Pacific Time) on ...
Breaking Medicine Technology:Touro College Announces Support for CanniCare's Medical Cannabis License Application 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4
(Date:7/29/2015)... ... 2015 , ... Toronto native Douglas James Cottrell, Ph.D., has ... been making predictions about the economy, politics, social issues, as well as the ... warns that extreme weather conditions and increased earthquake / volcanic activity will increase ...
(Date:7/29/2015)... ... 29, 2015 , ... " mybody ” was featured on NewsWatch as part ... businesses making an impact in their industry. Andrew Tropeano, the host of NewsWatch and ... skincare products are designed to strengthen the skin’s defense system from the inside out. ...
(Date:7/29/2015)... ... July 29, 2015 , ... National ... provider of life insurance, annuities, employee benefits and asset management, has joined as ... sporting event taking place in Charlotte, North Carolina on October 2-4, 2015. , ...
(Date:7/29/2015)... , ... July 29, 2015 , ... People that are ... two new products on Mercola.com: a vertical “garden tower” and enhanced mineral product for ... squeezed into small corners on a porch, balcony, or rooftop – can hold up ...
(Date:7/29/2015)... DC (PRWEB) , ... July 29, 2015 , ... ... aluminum-related illnesses is seeking funding for a study on the potentially lifesaving impact ... Research Institute today . , The research proposal is based on a ...
Breaking Medicine News(10 mins):Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3
... to researchers, chemotherapy brings about long lasting modifications in ... responsible// for the mental fog and confusion in several ... researchers at the University of California, Los Angeles, revealed ... cortex in women who had undergone chemotherapy 5-10 years ...
... from over in Bihar with the detection of new cases ... immunisation drive this year//. ,Eight districts of Magadh and ... cases were detected in Jehanand, while one each came up ... new cases of polio, an official said. ,Keeping the ...
... daily physical exercise for their future good health, says a ... children at 36 nurseries in Glasgow. ,The researchers ... exercise - 30 minutes, three times a week, reported the ... was not enough to affect the children's body mass index ...
... experts, some cancer patients are experiencing unjust dismissal and ... legislation to protect their rights//. ,The Disability ... last year has provided effective protection at work to ... the Disability Rights Commission (DRC) has reported that 200 ...
... has received a shot in the arm by way of ... have found that Aspirin is endowed with the potential to ... the bud. Indeed, this information may throw open a plethora ... Dr Helen Arthur of Newcastle University, previous research has indicated ...
... patients with schizophrenia whose medication is changed because ... drugs do not appear to offer significant benefits ... report in the October issue of Archives of ... ,The findings run contrary to the widely ...
Cached Medicine News:Health News:Chemotherapy causes mental fog 2Health News:Injustice to cancer patients at work 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 3
Shandon Paraffin Block Cartons...
... histological embedment block cataloging ... file system incorporates the ... block protection, simplified cataloging, ... and facilitation of retrieval. ...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: